Personalized medicine: A patient - centered paradigm

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Chouchane, Lotfi ^a   Mamtani, Ravinder ^a   Dallol, Ashraf ^b   Sheikh, Javaid I ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

TRASTUZUMAB; WARFARIN;

BREAST CANCER; DIABETES MELLITUS; DIET; DISABILITY; DOCTOR PATIENT RELATION; EDITORIAL; GENETIC VARIABILITY; GENOMICS; GENOTYPE; HEART DISEASE; HUMAN; LIFESTYLE; MORTALITY; PATIENT PARTICIPATION; PERSONALIZED MEDICINE; PREVENTIVE MEDICINE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING CESSATION; THROMBOEMBOLISM; TUMOR SUPPRESSOR GENE; WEIGHT REDUCTION; BREAST TUMOR; FEMALE; GENETICS; HEALTH CARE DELIVERY; PATIENT CARE; PHARMACOGENETICS;

BREAST NEOPLASMS; DELIVERY OF HEALTH CARE; FEMALE; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; LIFE STYLE; PATIENT-CENTERED CARE; PHARMACOGENETICS; PHYSICIAN-PATIENT RELATIONS; WARFARIN;

EID: 82355186479     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-206     Document Type: Editorial

References (11)

1. Hong K-W, Oh B. Overview of personalized medicine in the disease genomic era. BMB Reports 2010, 43:643-8. 10.5483/BMBRep.2010.43.10.643, 21034525.
2. Kamali F, Wynee H. Pharmacogenetics of warfarin. Annu Rev Med 2010, 61:63-75. 10.1146/annurev.med.070808.170037, 19686083.
3. Voora D, McLeod HL, Eby C, Gage BF. The pharmacogenetics of coumarin therapy. Pharmacogenomics 2005, 6:503-513. 10.2217/14622416.6.5.503, 16014000.
4. Rettie AE, Tai G. The pharmacogenomics of warfarin: closing in on personalized medicine. Mol Interv 2006, 6:223-227. 10.1124/mi.6.4.8, 16960144.
5. Flockhart DA, O'Kane D, Williams MS, et al. Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med 2008, 10:139-150. 10.1097/GIM.0b013e318163c35f, 18281922.
6. Goldenberg MM. Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 1999, 21:309-318. 10.1016/S0149-2918(00)88288-0, 10211534.
7. Self Care Report, Department of Health, UK. , http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasse t/dh_076932.pdf
8. Di Blasi Z, Harkness E, Ernst E, Georgioud A, Kleijnen J. Influence of context effects on health outcomes: a systematic review. The Lancet 2001, 37:757-762.
9. Everson SA, Kaplan GA, Goldberg DE, Salonen R, Salonen JT. Hopelessness and 4-year progression of carotid atherosclerosis. The Kuopio Ischemic Heart Disease Risk Factor Study. Arterioscler Thromb Vasc Biol 1997, 17:1490-495. 10.1161/01.ATV.17.8.1490, 9301625.
10. Armstrong D. 'Public health spaces and the fabrication of identity':. Sociology 1993, 27:393-410.
11. Furmark T, Appel L, Henningsson S, et al. A link between serotinin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. The Journal of Neuroscience 2008, 28:13066-13074. 10.1523/JNEUROSCI.2534-08.2008, 19052197.